| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 10/11/2006 | EP1709039A1 Metallic complexes used as light-absorbent compounds in the information layer of optical data carriers |
| 10/11/2006 | EP1709038A2 A process for the preparation of 5- 4- 2- n-methyl -n-(2-pyridyl) amino ethoxy phenyl methyl thiaz olidine-2, 4-dione maleate |
| 10/11/2006 | EP1709037A2 Hiv protease inhibiting sulfonamides |
| 10/11/2006 | EP1709036A1 Thiazole derivatives as a2b antagonists |
| 10/11/2006 | EP1709035A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 10/11/2006 | EP1709019A2 Thiazole derivatives and use thereof |
| 10/11/2006 | EP1709018A1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 10/11/2006 | EP1709006A1 Benzimidazole derivatives |
| 10/11/2006 | EP1708997A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
| 10/11/2006 | EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 10/11/2006 | EP1708703A2 Chemokine receptor binding compounds |
| 10/11/2006 | EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 10/11/2006 | EP1708701A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 10/11/2006 | EP1708699A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- k .b activity and use thereof |
| 10/11/2006 | EP1708697A2 Chemical compounds |
| 10/11/2006 | EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/11/2006 | EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 10/11/2006 | EP1363903B1 Indole derivatives and their use as gnrh antagonists |
| 10/11/2006 | EP0944619B1 Novel integrin receptor antagonists |
| 10/11/2006 | CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 10/11/2006 | CN1845924A Arylamine-substituted quinazolinone compounds |
| 10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
| 10/11/2006 | CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 10/11/2006 | CN1845911A Condensed ring compound and use thereof |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845673A Pyridinylanilides |
| 10/11/2006 | CN1279039C Hetaryl substituted homotetramic and homotetramic acids and the use thereof as pesticides |
| 10/11/2006 | CN1279034C Dna－pk抑制剂 Dna-pk inhibitors |
| 10/11/2006 | CN1279033C Improved method for water soluble azole compounds |
| 10/11/2006 | CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 10/10/2006 | US7119209 Process for preparing indolinone derivatives |
| 10/10/2006 | US7119208 drugs that bind to and increases oxygen affinity of hemoglobin, and preventing polymerization and formation fibrous precipitates hemoglobin, used for treatment of sickle-cell disease |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
| 10/10/2006 | US7119196 Anxiolytic agents with reduced sedative and ataxic effects |
| 10/10/2006 | US7119115 For therapy of treating tumors or cancerous cells |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts |
| 10/10/2006 | US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist |
| 10/10/2006 | US7119089 Phenothiazine kinesin inhibitors |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7118844 Storage stability and light fixation properties; synthesis intermediate for azo dye, an analytical reagent |
| 10/10/2006 | US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same |
| 10/10/2006 | CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 10/05/2006 | WO2006105289A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | WO2006105262A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl |
| 10/05/2006 | WO2006104897A2 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | WO2006104713A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | WO2006104646A1 Hiv protease inhibitors |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/05/2006 | WO2006103068A1 A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists |
| 10/05/2006 | WO2006103057A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006103045A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006103011A1 Pharmaceutical preparation of n -[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 10/05/2006 | WO2006072458A3 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 10/05/2006 | WO2006044825A3 Mitotic kinesin inhibitors and methods of use thereof |
| 10/05/2006 | WO2005115392A8 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 10/05/2006 | US20060223994 Novel polymorph of Quetiapine fumarate and a process for its preparation |
| 10/05/2006 | US20060223886 Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 10/05/2006 | US20060223868 Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1) |
| 10/05/2006 | US20060223864 Thiadiazoles AS CXC- and CC- chemokine receptor ligands |
| 10/05/2006 | US20060223850 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 10/05/2006 | US20060223849 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors |
| 10/05/2006 | US20060223833 inhibitors of polo-like kinases; (4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-[3-ethyl-4-oxo-5-[1-[3-(2-pyrrolidin-1-yl-ethyl)-phenylamino]-meth-(E/Z)-ylidene]-thiazolidin-(2-(E or Z))-ylidene]-acetonitrile; cancer, auto-immune diseases, cardiovascular diseases |
| 10/05/2006 | US20060223826 Indole derivatives as somatostatin agonists or antagonists |
| 10/05/2006 | US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223801 Pyrrol derivatives with antibacterial activity |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | US20060223076 Cyanine dyes and their applications as luminescence quenching compounds |
| 10/05/2006 | DE102005014248A1 Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid A pharmaceutical preparation of N- [5- (aminosulfonyl) -4-methyl-1,3-thiazol-2-yl] -N-methyl-2- [4- (2-pyridinyl) phenyl] acetamide |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/05/2006 | CA2603322A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | CA2602750A1 Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide |
| 10/05/2006 | CA2602574A1 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | CA2602510A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | CA2602339A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602336A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602254A1 Pharmacokinetically improved compounds |
| 10/04/2006 | EP1706399A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | EP1706395A1 Thiophene and furan compounds |
| 10/04/2006 | EP1706391A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-&(k)beta activity and use thereof |
| 10/04/2006 | EP1706384A1 Therapeutic agents i |
| 10/04/2006 | EP1706380A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/04/2006 | EP1706379A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/04/2006 | EP1705990A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 10/04/2006 | EP1492786B1 Pyridinoylpiperidines as 5-ht1f agonists |
| 10/04/2006 | EP1425008B1 Use of substituted aminomethyl chromans in the treatment of side effects of neuroleptics |
| 10/04/2006 | EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 10/04/2006 | EP1406900B1 Novel compounds, their preparation and use |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | CN1842524A 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |